Compare MDU & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | ICUI |
|---|---|---|
| Founded | 1924 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.9B |
| IPO Year | 1994 | 1995 |
| Metric | MDU | ICUI |
|---|---|---|
| Price | $21.46 | $127.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $21.67 | ★ $174.33 |
| AVG Volume (30 Days) | ★ 1.3M | 224.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | ★ 0.93 | 0.03 |
| Revenue | $1,875,066,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $6.00 | $4.46 |
| P/E Ratio | ★ $23.48 | $4,373.33 |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $15.76 | $107.02 |
| 52 Week High | $22.47 | $160.29 |
| Indicator | MDU | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 47.86 |
| Support Level | $19.94 | $121.48 |
| Resistance Level | $22.47 | $133.62 |
| Average True Range (ATR) | 0.42 | 4.36 |
| MACD | -0.02 | 1.14 |
| Stochastic Oscillator | 45.41 | 67.87 |
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States. The majority of its revenues is generated from the Natural Gas distribution segment.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.